Replies to post #73223 on Biotech Values

[exwannabe]

Re: Bio Buyouts

I would argue that a more reasonable number to put up for IDEV would be $5.4 a share (where the market has generally valued it).

That would be a 74% premium.

Yes, I know this makes the process somewhat fuzzy, but clearly more accurate. Especially given the fact and investor can cash out at that number.

I imagine several others have the same issue.